Compare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIAN HEALTHCARE vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIAN HEALTHCARE TORRENT PHARMA CIAN HEALTHCARE/
TORRENT PHARMA
 
P/E (TTM) x - 39.8 - View Chart
P/BV x 0.7 8.6 8.6% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 CIAN HEALTHCARE   TORRENT PHARMA
EQUITY SHARE DATA
    CIAN HEALTHCARE
Mar-20
TORRENT PHARMA
Mar-21
CIAN HEALTHCARE/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs633,040 2.1%   
Low Rs121,933 0.6%   
Sales per share (Unadj.) Rs24.4473.0 5.2%  
Earnings per share (Unadj.) Rs-1.674.0 -2.2%  
Cash flow per share (Unadj.) Rs0.3112.9 0.3%  
Dividends per share (Unadj.) Rs035.00 0.0%  
Avg Dividend yield %01.4 0.0%  
Book value per share (Unadj.) Rs24.9344.9 7.2%  
Shares outstanding (eoy) m23.36169.22 13.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.55.3 29.2%   
Avg P/E ratio x-23.233.6 -68.9%  
P/CF ratio (eoy) x132.822.0 602.7%  
Price / Book Value ratio x1.57.2 20.9%  
Dividend payout %047.3 0.0%   
Avg Mkt Cap Rs m878420,798 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m4014,396 0.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m57180,048 0.7%  
Other income Rs m9757 1.1%   
Total revenues Rs m58080,806 0.7%   
Gross profit Rs m7324,666 0.3%  
Depreciation Rs m446,578 0.7%   
Interest Rs m723,583 2.0%   
Profit before tax Rs m-3515,263 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m32,744 0.1%   
Profit after tax Rs m-3812,519 -0.3%  
Gross profit margin %12.730.8 41.4%  
Effective tax rate %-7.518.0 -41.5%   
Net profit margin %-6.615.6 -42.4%  
BALANCE SHEET DATA
Current assets Rs m76955,232 1.4%   
Current liabilities Rs m50048,916 1.0%   
Net working cap to sales %47.07.9 595.9%  
Current ratio x1.51.1 136.1%  
Inventory Days Days6514 454.7%  
Debtors Days Days1287 1,839.6%  
Net fixed assets Rs m79681,298 1.0%   
Share capital Rs m234846 27.6%   
"Free" reserves Rs m34857,526 0.6%   
Net worth Rs m58258,372 1.0%   
Long term debt Rs m45829,633 1.5%   
Total assets Rs m1,564136,530 1.1%  
Interest coverage x0.55.3 9.7%   
Debt to equity ratio x0.80.5 155.2%  
Sales to assets ratio x0.40.6 62.2%   
Return on assets %2.211.8 18.6%  
Return on equity %-6.521.4 -30.3%  
Return on capital %3.521.4 16.6%  
Exports to sales %9.00-   
Imports to sales %0.10-   
Exports (fob) Rs m52NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5221,539 0.2%   
Fx outflow Rs m07,136 0.0%   
Net fx Rs m5114,403 0.4%   
CASH FLOW
From Operations Rs m-8420,107 -0.4%  
From Investments Rs m-274-4,494 6.1%  
From Financial Activity Rs m369-16,561 -2.2%  
Net Cashflow Rs m10-893 -1.2%  

Share Holding

Indian Promoters % 70.9 71.3 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 20.3 -  
FIIs % 0.0 11.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 28.8 101.3%  
Shareholders   361 64,309 0.6%  
Pledged promoter(s) holding % 10.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIAN HEALTHCARE With:   JUBILANT INGREVIA  GSK PHARMA  BHARAT PARENTALS  LYKA LABS  GLENMARK PHARMA  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIAN HEALTHCARE SHARE PRICE


Oct 21, 2021 (Close)

TRACK CIAN HEALTHCARE

  • Track your investment in CIAN HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CIAN HEALTHCARE

CIAN HEALTHCARE 8-QTR ANALYSIS

COMPARE CIAN HEALTHCARE WITH

MARKET STATS